Morningstar

Morningstar, Inc.

Equity Bottom-Up

No-moat Hill-Rom reported fiscal second-quarter results that largely fell in line with our expectations. After sifting through the release, incorporating the firm's recently closed acquisition of privately held Voalte, and assessing management's updated guidance, we don't expect our $84 fair value estimate to change much
While the firm's performance has accelerated in recent quarters, our valuation concerns are in the sustainability of its revenue growth. Updated guidance suggests core revenue…

United States

Hill-Rom Holdings, Inc. manufactures equipment for the healthcare industry, and provides wound care and pulmonary/trauma management services.  The Company produces hospital beds, mattresses, stretchers, furniture and hospital information technology systems; and offers wound, circulatory and pulmonary therapies.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00